CXCL10 and neoplasm: Although the magnitude of changes of IFN-β, CXCL10, and a variety of chemokines and cytokines following SFN treatment varies substantially among different cHL cell lines, they ultimately seem to contribute to anti-tumor immune responses as demonstrated by functional increase in natural killer (NK) cell-mediated killing of cHL cells in vitro (Fig. 1D).